161 related articles for article (PubMed ID: 35244767)
1. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
Witting N; Daugaard D; Prytz S; Biernat H; Diederichsen LP; Vissing J
J Neurol; 2022 Aug; 269(8):4154-4160. PubMed ID: 35244767
[TBL] [Abstract][Full Text] [Related]
2. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Youssof S; Schrader RM; Romero-Clark C; Roy G; Spafford M
Muscle Nerve; 2014 Apr; 49(4):601-3. PubMed ID: 24259282
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis.
Schrey A; Airas L; Jokela M; Pulkkinen J
J Neurol Sci; 2017 Sep; 380():142-147. PubMed ID: 28870555
[TBL] [Abstract][Full Text] [Related]
4. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis.
Liu LW; Tarnopolsky M; Armstrong D
Can J Gastroenterol; 2004 Jun; 18(6):397-9. PubMed ID: 15190396
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin A Injection Using Esophageal Balloon Radiography Combined with CT Guidance for the Treatment of Cricopharyngeal Dysphagia.
Huai J; Hou Y; Guan J; Zhang Y; Wang Y; Zhang X; Zhang Y; Yue S
Dysphagia; 2020 Aug; 35(4):630-635. PubMed ID: 31620859
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in the treatment of cricopharyngeal dysphagia.
Haapaniemi JJ; Laurikainen EA; Pulkkinen J; Marttila RJ
Dysphagia; 2001; 16(3):171-5. PubMed ID: 11453562
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia.
Di Pede C; Masiero S; Bonsangue V; Ragona RM; Del Felice A
Neurol Sci; 2016 Oct; 37(10):1743-5. PubMed ID: 27098244
[No Abstract] [Full Text] [Related]
8. Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.
Manjaly JG; Vaughan-Shaw PG; Dale OT; Tyler S; Corlett JC; Frost RA
Dysphagia; 2012 Jun; 27(2):216-20. PubMed ID: 21805106
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic-guided injection of botulinum toxin into the cricopharyngeus muscle: our experience.
Sharma SD; Kumar G; Eweiss A; Chatrath P; Kaddour H
J Laryngol Otol; 2015 Oct; 129(10):990-5. PubMed ID: 26446761
[TBL] [Abstract][Full Text] [Related]
10. A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD).
Waito AA; Steele CM; Peladeau-Pigeon M; Genge A; Argov Z
Dysphagia; 2018 Dec; 33(6):789-802. PubMed ID: 29725764
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases].
Yokoyama T; Asai M; Kumada M; Usui S; Kobayasi T
Nihon Jibiinkoka Gakkai Kaiho; 2003 Jul; 106(7):754-7. PubMed ID: 12931643
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction.
Jeong SH; Kim YJ; Kim YJ; Park KD; Kim EJ; Chung JW; Kwon KA; Kim KO; Park DK; Kim JH; Cho JH
Scand J Gastroenterol; 2018; 53(10-11):1201-1205. PubMed ID: 30353754
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin for dysphagia due to cricopharyngeal dysfunction.
Moerman M; Callier Y; Dick C; Vermeersch H
Eur Arch Otorhinolaryngol; 2002 Jan; 259(1):1-3. PubMed ID: 11954918
[TBL] [Abstract][Full Text] [Related]
14. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Restivo DA; Marchese-Ragona R
Muscle Nerve; 2014 Nov; 50(5):869-70. PubMed ID: 25155080
[No Abstract] [Full Text] [Related]
15. Interventions for dysphagia in long-term, progressive muscle disease.
Jones K; Pitceathly RD; Rose MR; McGowan S; Hill M; Badrising UA; Hughes T
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD004303. PubMed ID: 26859621
[TBL] [Abstract][Full Text] [Related]
16. Design and implementation of botulinum toxin on cricopharyngeal dysfunction guided by a combination of catheter balloon, ultrasound, and electromyography (BECURE) in patients with stroke: study protocol for a randomized, double-blinded, placebo-controlled trial.
Xie M; Dou Z; Wan G; Zeng P; Wen H
Trials; 2021 Mar; 22(1):238. PubMed ID: 33789722
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin improves dysphagia associated with multiple sclerosis.
Restivo DA; Marchese-Ragona R; Patti F; Solaro C; Maimone D; Zappalá G; Pavone A
Eur J Neurol; 2011 Mar; 18(3):486-90. PubMed ID: 20731706
[TBL] [Abstract][Full Text] [Related]
18. Cricopharyngeal muscle hypertrophy associated with florid myositis.
Bachmann G; Streppel M; Krug B; Neuen-Jacob E
Dysphagia; 2001; 16(4):244-8. PubMed ID: 11720399
[TBL] [Abstract][Full Text] [Related]
19. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter.
Murry T; Wasserman T; Carrau RL; Castillo B
Am J Otolaryngol; 2005; 26(3):157-62. PubMed ID: 15858769
[TBL] [Abstract][Full Text] [Related]
20. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
